Miradx Is A Molecular Genetics Company Based In Los Angelesco Founded In 2008 By Drjoanne Weidhaas And Drfrank Slackthe Company Is Dedicated To Advancing Personalized Medicine Through The Use Of Germline Genetic Biomarkersparticularly Focusing On Microrna Biologythis Approach Aims To Optimize Cancer Treatment Strategies And Predict Therapy Related Toxicities Miradx Operates A Clia Certified Laboratory And Has Shown Adaptability By Providing Covid 19 Testing For Essential Workers During The Pandemicthe Company Collaborates With Academic And Industry Partners Globally To Enhance Biomarker Applicationsits Offerings Include Kras Variant Testingwhich Helps Guide Cancer Treatment Decisionsand In Development Tests Like Previotox And Prostoxdesigned To Assess Risks Associated With Immunotherapy And Personalize Radiation Therapy Recommendationsrespectivelymiradx Primarily Serves Oncologists And Cancer Patientswith A Commitment To Improving Treatment Outcomes Through Innovative Genetic Insights
No conferences found for this company.
| Company Name | Miradx Inc |
| Country |
United States
|
| Address | N/A |
| Telephone | N/A |
| N/A |
